Your session is about to expire
← Back to Search
ESP Block with Ropivacaine for Postoperative Pain
Study Summary
This trial will investigate whether adding a continuous infusion of a local anesthetic to a single-shot erector spinae plane block (ESPB) provides better pain relief and fewer side effects than a placebo infusion for people undergoing multilevel spine surgery.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am between 18 and 80 years old.My surgery will be done from the back.I have been taking more than 60 mg of morphine daily for over 3 months.I have chosen not to participate in this trial.My surgery involves the lower back, mid-back, or both.I am scheduled for a spinal fusion surgery involving more than two spinal levels.I have been taking gabapentin or pregabalin daily for more than 3 months.I have had spine surgery at the specific area being studied.I am not allergic and do not have conditions that prevent me from taking the study medications.
- Group 1: ESP Catheters with Ropivacaine 0.2%
- Group 2: ESP Catheters with Saline Solution
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants have been added to the research study?
"Affirmative, the details posted on clinicaltrials.gov demonstrate that this medical study is actively recruiting patients. After being put up on September 14th 2022, it was last updated a month later; 44 people are required to be enrolled at one centre."
Does this clinical trial encompass elderly individuals?
"As delineated in the study's eligibility requirements, potential participants must be at least 18 years old and no older than 80."
Is this experiment now open to recruitment?
"This clinical trial is still accepting patients, as evidenced by its last update on October 28th. It was initially posted six weeks prior on September 14th."
Who qualifies to participate in this research project?
"A total of 44 individuals, aged between 18 and 80 who have undergone spinal surgery are eligible for this trial. In addition, applicants should comply with the following conditions: lumbar/thoracic/thoracolumbar fusion operations; readiness to abide by the study protocols; providing informed consent and undergoing a posterior surgical approach."
Share this study with friends
Copy Link
Messenger